Cargando…

487 Infections Caused by Enterobacteriaceae Species following Cardiac Surgery: Impact of Polymyxin Resistance on Treatment Outcomes

Detalles Bibliográficos
Autores principales:	Abboud, Cely Saad, Jacobs, David, Monteiro, Jussimara, Zandonadi, Eliana De Cassia, Barbosa, Vera Lucia, Forrest, Alan, Rao, Gauri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782022/ http://dx.doi.org/10.1093/ofid/ofu052.353

Ejemplares similares

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis()
por: Abboud, Cely Saad, et al.
Publicado: (2017)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

959 Epidemiology and Treatment of Enterobacteriaceae Bacteremia: Combination vs Monotherapy
por: Berkowitz, Nina, et al.
Publicado: (2014)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

359 Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) at an Academic Medical Center
por: Leiner, Charles, et al.
Publicado: (2014)

418 Antimicrobial Profile of Enterobacteriaceae from North America from 2013
por: Johnson, Brian, et al.
Publicado: (2014)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

364 Utility of Carbapenem-Resistant Enterobacteriaceae Surveillance Cultures in Predicting Clearance of Colonization
por: Lewis, Jessica, et al.
Publicado: (2014)

424 Characterization and Profiling of Multi-Drug Resistant (MDR) Enterobacteriaceae From Latin America
por: Renteria, Martha, et al.
Publicado: (2014)

253 Activity of Eravacycline Against Enterobacteriaceae and Acinetobacter baumannii from New York City
por: Abdallah, Marie, et al.
Publicado: (2014)

249 Activity of Plazomicin Against Contemporary Isolates of Enterobacteriaceae from New York City
por: Olafisoye, Olawole, et al.
Publicado: (2014)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

479 Clinical outcomes in patients with extended-spectrum-beta-lactamase-producing (ESBL) Enterobacteriaceae bloodstream infections (ESB) treated with carbapenems (CP) and non-carbapenems (NC)
por: Chin, Judy, et al.
Publicado: (2014)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

355 Carbapenem-Resistant Enterobacteriaceae (CRE) Distribution within the Veterans Affairs Healthcare System: 2013
por: Ryono, Russell, et al.
Publicado: (2014)

260 Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae
por: Popejoy, Myra, et al.
Publicado: (2014)

434 Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies
por: Satlin, Michael J., et al.
Publicado: (2014)

1726 What Defines Carbapenem-Resistant Enterobacteriaceae (CRE) in a Low Prevalence State? Oregon, 2010 — 2013
por: Maureen Cassidy, P., et al.
Publicado: (2014)

423 Comparison of pediatric community-acquired, healthcare-associated, and hospital-acquired infections caused by extended-spectrum cephalosporin-resistant Enterobacteriaceae
por: Adler, Amanda, et al.
Publicado: (2014)

421 Activity of Tigecycline and Comparators Against Lower Respiratory Tract (LRT) Isolates of Enterobacteriaceae from North America and Europe: 2009-2013
por: Hoban, Daryl, et al.
Publicado: (2014)

331 Risk Factors for Vancomycin-resistant Enterococci and Carbapenemase-producing Carbapenem-resistant Enterobacteriaceae Colonization at admission to a Tertiary-care Center
por: Chow, Angela, et al.
Publicado: (2014)

347 Antimicrobial Susceptibility of OXA-48, NDM-1 And VIM-4 Carbapenemase-producing Clinical Isolates of Enterobacteriaceae From Kuwait Government Hospitals
por: Jamal, Wafaa, et al.
Publicado: (2014)

363 Persistence of the Klebsiella pneumoniae Sequence Type 258 as the Predominant Clone of Carbapenemase-Producing Enterobacteriaceae in Post-Acute Care Facilities in Israel, 2008-2013
por: Adler, Amos, et al.
Publicado: (2014)

257 In Vitro Activity of Meropenem/RPX7009, a Carbapenem/β-lactamase Inhibitor Combination Tested Against Contemporary Populations of Enterobacteriaceae and KPC-producing Strains
por: Castanheira, Mariana, et al.
Publicado: (2014)

341 Heterogeneous regional distribution of nosocomial infections due to ESBL-producing Enterobacteriaceae in Germany: Data from the German National Reference Center for the Surveillance of Nosocomial Infections (KISS)
por: Leistner, Rasmus, et al.
Publicado: (2014)

398 Pharmacokinetics of dalbavancin (DAL) in bone and associated tissues in patients undergoing orthopedic surgical procedures
por: Baldassarre, James, et al.
Publicado: (2014)

250 Ceftazidime-avibactam Activity Tested Against a Large Collection of Enterobacteriaceae Isolates Collected in United States (USA) Hospitals in the 2011-2013 Period, Including Organisms Producing KPC- and CTX-M-variants
por: Castanheira, Mariana, et al.
Publicado: (2014)

217 The Oregon Antimicrobial Stewardship Collaborative (OASIS). Statewide Effectiveness on Re-Survey
por: Mohammadi, Jwan, et al.
Publicado: (2014)

Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae
por: Diep, John K., et al.
Publicado: (2018)

478 Daptomycin Susceptible vs Nonsusceptible Enterococcus faecium Bacteremias: Comparison of Clinical and Microbiological Outcomes
por: Lee, Spencer, et al.
Publicado: (2014)

607 Identification of Viral Infection Using a Polymerase Chain Reaction (PCR)-based Respiratory Virus Panel (RVP) Decreases Antibacterial Use
por: Rokas, Kristina, et al.
Publicado: (2014)

173 Introduction of Procalcitonin Testing Did Not Reduce Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Rao, Krishna, et al.
Publicado: (2014)

1676 Salivary Levels of Streptococcus mutans in Individuals with Temporomandibular Disorders
por: Galvão-Moreira, Leonardo Victor, et al.
Publicado: (2014)

857 A Case Control Study of the Risk Factors for Central Venous Catheter Related Mixed Candidemia Infection
por: Varma, Dantuluru Muralidhar, et al.
Publicado: (2014)

1293 Clinical Characteristics of Botulism in the United States, 2002–2012
por: Rao, Agam K., et al.
Publicado: (2014)

662 Missed opportunities for influenza vaccination among inpatients with influenza
por: Rao, Suchitra, et al.
Publicado: (2014)

1145 2009 H1N1 Compared to Post-pandemic H1N1 Influenza Among Pediatric Inpatients
por: Rao, Suchitra, et al.
Publicado: (2014)

352 Clinical and molecular characteristics of NDM-1 harboring Multi-Drug Resistant Gram Negative Bacteria at Carilion Medical Center
por: Bansal, Ekta, et al.
Publicado: (2014)

732 Predictors of Cardiac Implantable Electronic Device Infection in Patients with Staphylococcus Aureus Bacteremia
por: Elmalik, Hassan, et al.
Publicado: (2014)

1298 Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Means, Laura, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8jlpclupfa94jos1f8drvt63og